Key market opportunities in the global forensic genomics sector include advancements in DNA analysis, growing national DNA ...

It’s hard to imagine that a snail could kill a person, but a particularly venomous group of marine molluscs called cone ...

An international team uncovered 1,785 previously overlooked human microproteins called peptideins. By analyzing billions of ...

Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...

SUPRAME Phase 3 interim and final analysis for PRAME cell therapy, anzu-cel, expected to be triggered in 2026, advancing ...

Glioblastoma remains one of the most lethal primary brain tumors, with limited durable benefit from current standard-of-care approaches. In parallel, ...

Skull-base tumors, a subset of neoplasms, present a formidable challenge in the field of oncology due to their complex anatomical location at the interface of the brain and skull-base. These tumors ...

In April 2021, a team of researchers at the Earlham Institute was not looking for anything extraordinary. They were testing a ...

The National Biotechnology Research and Development Agency (NBRDA) has launched a National Genomics and Bioinformatics Data Generation, Repository, and Management Infrastructure aimed at advancing ...

Breakthroughs in gene editing, AI-driven drug discovery, and in vivo CAR-T therapies are moving from experimental stages to clinical and commercial reality in 2026. Regulatory reforms, market rebounds ...

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but imperfect antibiotic candidates into more potent ones. Unlike many existing AI ...

University of Pennsylvania researchers have developed ApexGO, an AI system that refines imperfect antibiotic candidates ...